title: Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse.
authors.forename: V
authors.initials: V
authors.lastname: de Haas
authors.forename: W B
authors.initials: WB
authors.lastname: Breunis
authors.forename: O J
authors.initials: OJ
authors.lastname: Verhagen
authors.forename: H
authors.initials: H
authors.lastname: van der Berg
authors.forename: C E
authors.initials: CE
authors.lastname: van der Schoot
mesh_terms: D002051:Burkitt Lymphoma / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D012008:Recurrence